 |
|
|
23-11-2006
The recent trend towards community psychiatry appears to have shifted much of the burden of care of the chronically mentally ill from the institutions to the family. The objective of this study was to assess the implication of psychopathology in forty five schizophrenic patients on burden experience by their primary caregivers...
» Read more...
|
23-11-2006
Objective: To highlight the alternative and effective management strategies of behavioural disturbances in severe dementia without the use of physical restraints.
» Read more...
|
22-11-2006
Quetiapine has received approval from the US Food and Drug Administration (FDA) for the treatment of depressive episodes in patients with bipolar disorder...
» Read more...
|
21-11-2006
Background: Selective serotonin reuptake inhibitors (SSRIs) have increasingly replaced tricyclic antidepressants (TCAs) in the treatment of depression. They appear to be safer in overdose, but there is little information on their spectrum of toxicity in overdose, or relative toxicity of each agent.
» Read more...
|
21-11-2006
The safety profile of the selective serotonin reuptake inhibitor, fluvoxamine, has been assessed in clinical and post-marketing studies...
» Read more...
|
21-11-2006
Behavioral models used to test potential antidepressants have shown that ligands that bind to sigma receptors possess “antidepressant-like” properties. The focus of this review is to discuss the literature concerning sigma receptors and their ligands, with respect to their antidepressant properties...
» Read more...
|
|
|
